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Abstract
Background: To investigate in a cohort with previous gastrointestinal infection and a control group the prevalence
of overactive bladder syndrome (OAB), and how it was associated with three other functional disorders; irritable
bowel syndrome (IBS), functional dyspepsia (FD) and chronic fatigue (CF).
Methods: Controlled historic cohort study including 724 individuals with laboratory confirmed giardiasis six years
earlier, and 847 controls matched by gender and age. Prevalence and odds ratios (OR) with 95 % confidence
intervals (CI) were calculated.
Results: The prevalence of OAB was 18.7 % (134/716) in the exposed group and 13.6 % (113/833) in the control
group (p = 0.007). The association between OAB and IBS was strong in the control group (OR: 2.42; 95 % CI: 1.45
to 4.04), but insignificant in the Giardia exposed (OR: 1.29; 95 % CI: 0.88 to 1.88). The association between OAB and
FD was weak in both groups. CF was strongly associated with OAB (OR: 2.73; 95 % CI: 1.85 to 4.02 in the exposed
and OR: 2.79; 95 % CI: 1.69 to 4.62 in the controls), and this association remained when comorbid conditions
were excluded.
Conclusions: Sporadic IBS was associated with increased risk of OAB, whereas post-infectious IBS was not. An
apparent association between OAB and previous Giardia infection can be ascribed to comorbid functional disorders.
Keywords: Giardia lamblia, Irritable bowel syndrome, Dyspepsia, Urinary bladder, overactive, Fatigue syndrome,
chronic, Comorbidity
Background
Disorders termed “functional” designate the presence of
certain symptoms in the absence of physiological or
biochemical abnormalities that would otherwise explain
their existence [1]. Examples of functional disorders in-
clude irritable bowel syndrome (IBS), functional dyspep-
sia (FD), chronic fatigue syndrome (CFS) and overactive
bladder syndrome (OAB). Functional disorders have
been reported to follow after bacterial, viral and parasitic
infections. Salmonella and Campylobacter gastroenter-
itis, mycoplasma infection, Lyme disease and glandular
fever are some examples of common infectious diseases
shown to be associated with functional disorders [2–4].
Additionally, functional disorders often occur concomi-
tantly in patients [5], but the co-occurrence of these dis-
orders, and their relationship to prior infectious disease,
have been little investigated.
The present study is derived from a cohort formed after
a large waterborne outbreak of gastroenteritis caused by
the parasite Giardia lamblia in the city of Bergen, Norway
in 2004. It was previously demonstrated that there is a
strong association between giardiasis and risk of IBS both
3 and 6 years after the initial infection [6, 7]. Previous
studies also suggest an association between gastro-
intestinal infection and FD [2].
OAB is a common urological disorder consisting of
urinary urgency accompanied by urgency incontinence,
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frequency or nocturia in which no precise cause can be
identified [8]. It has been shown that individuals with
IBS more frequently display signs of bladder dysfunction
[9], including symptoms comprising OAB [10–12]. One
study similarly suggests that a comparable association
exists between OAB and FD [12].
CFS is a clinical syndrome characterized by persistent
fatigue in absence of explanatory medical or psychiatric
disorders [13]. Although not consistently present, several
infectious agents are suspected to incite CFS [2, 4]. While
OAB and other forms of bladder symptoms are supportive
criteria for CFS diagnosis [14], the rate of symptom over-
lap has not been established. Chronic fatigue (CF) outlines
the hallmark symptoms of CFS. CF can be assessed by the
use of a questionnaire and is therefore better suited for
epidemiological studies. We have previously demonstrated
an increased risk of CF following acute giardiasis [6, 7].
The objective of the current study was to investigate
the prevalence and risk of OAB in this cohort of Giardia
exposed individuals and a matched control group six
years after acute infection, and to determine its relation
to IBS, CF and FD.
Methods
Study design and participants
In 2004, a contamination of the main water supply reser-
voir caused an outbreak of giardiasis in the city of Bergen.
A cohort was established in 2007 comprising 1252 pa-
tients with laboratory confirmed giardiasis from the out-
break and 2504 controls matched by gender and age. The
control group was selected at random by Statistics Norway
from the entire population of Bergen, and individuals that
had had confirmed giardiasis before the outbreak were
excluded. The results in this study derive from a ques-
tionnaire that was mailed to the participants in October
2010. From the initial cohort 35 had died and 40 could
not be traced, leaving 1239 Giardia exposed and 2444
controls. Further description of study design has been
documented earlier [6, 7].
Variables
Acknowledging that “functional disorders” is an inad-
equate term, we still use this term in the current study
to designate four disorders: OAB, IBS, CF and FD. The
term comorbidity is used to describe concomitant occur-
rence of two or more of these functional disorders.
IBS and FD were defined using the Rome III criteria
[15]. IBS is defined as recurrent abdominal pain or dis-
comfort at least 3 days a month in the past 3 months
prior to the survey and associated with at least two of
the three criteria related to defecation (onset associated
with a change in frequency of stool, onset associated
with a change in consistency of stool, or improvement of
symptoms with defecation) [16]. The criteria for FD is
having either epigastric burning or pain, postprandial full-
ness, or early satiation, in the past 6 months in absence of
structural disease [17]. Structural disease was considered
to be excluded if respondents specified that they had not
been diagnosed with disease in the oesophagus or stom-
ach for the last 3 years. The list was reviewed together
with a specialist in gastroenterology and respondents were
excluded if the given response was able to explain the
symptoms. Respondents that were pregnant were also ex-
cluded from diagnosis.
The prevalence of fatigue was determined using the
Fatigue Questionnaire consisting of 11 questions [18].
The responses include a 4-level graded reply concerning
different aspects of fatigue and responses were thereafter
dichotomized based on severity. The questionnaire was
accepted if ≥ 7 of the 11 questions were answered; to
which any unanswered questions were assigned the mean
value of that particular question. For classification of CF
the respondent was required to have met the criteria for
at least four of the 11 questions, in addition to having
symptom duration of at least 6 months.
According to the standardized terminology by the
International Continence Society (ICS), OAB is a symptom
complex dominated by urinary urgency, with or without
urgency incontinence, and often accompanied by increased
urinary frequency and nocturia [8]. In a routine clinical
evaluation, accurate classification of OAB would also
require absence of underlying pathological conditions that
could explain the complaints. OAB was assessed using
the four-item International Consultation on Incontinence
Questionnaire (ICIQ-OAB) [19]. Questions on health-
related quality of life were excluded, thus only evaluating
the hallmark symptoms comprising OAB. The working
definition for frequency was set at > 8 micturitions per day.
The definition of nocturia was set as having to get up to
urinate > 1 time a night on average [20]. Urgency was de-
fined as rushing to the toilet to urinate at least ‘sometimes’,
which was also the defined cut off response for urgency in-
continence in response to a question about leakage of urine
before reaching the toilet. Our requirement for accepting
this part of the questionnaire was a response to at least 3
out of the 4 questions. To a missing response we assigned
a mean value of that particular question. OAB was there-
after defined as having met the diagnostic criteria for
urgency accompanied by at least one other OAB symptom,
in accordance with the ICS standardized definition [8].
Gender, age (three categories), marital status (four cat-
egories), level of education (three categories) and main
occupation (eight categories, reduced to four in the ana-
lyses) were included as demographic variables.
Analyses and statistical methods
Except for non-responder analyses, non-responders were
excluded from all analyses. Respondents with missing data
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were only accepted if the data was determined to be suffi-
cient for classification according to the established criteria
for each specific variable, the rest were excluded from ana-
lysis. As neither the Rome III criteria, nor the ICIQ-OAB
are suited for diagnostic evaluation for patients under the
age of 18, these respondents were excluded from the stat-
istical analyses.
We applied Pearson’s exact χ2 test for associations
in 2 × k tables. The attributable fraction in the ex-
posed (AFE) [21] was calculated from the relative risk
(RR) as a percentage using the following formula:
AFE = (1 − [1/RR]) × 100, and the CI was similarly
calculated from the CIs for RRs. Associations are reported
as odds ratios (OR) with 95 % confidence intervals (CI).
The Breslow-Day test for homogeneity was used to test
for comparing ORs between groups [22]. Level of statis-
tical significance was set at 0.05, and all tests were two-
sided. All analyses were done using SPSS version 20.
Ethical approval
This study was approved by the Regional Committee for
Medical and Health Research Ethics (project 150.07) and
by the Ombudsman for Privacy in Research, Norwegian
Social Science Data Services (project 17014).
Results
Response rates were 60.4 % (748/1239) for the Giardia
exposed and 36.3 % (888/2444) for controls. Seven re-
sponders in the control group were excluded as they re-
ported having had Giardia during the outbreak. Three
questionnaires were rejected for incomplete answers and
55 respondents were excluded who were below the age
of 18. This left us with 724 Giardia exposed and 847
controls available for analysis. The number of respon-
dents with missing data for each of the variables was 22
for OAB, 15 for IBS, 19 for CF and 65 for FD. Table 1
shows the population characteristics and demographics
for the Giardia exposed and control group.
Six years after the outbreak the prevalence of OAB
was 18.7 % (134/716) in the exposed group and 13.6 %
(113/833) in the control group (p = 0.007) (Table 2). The
AFE (i.e. the proportion of OAB in the Giardia cohort
that could have been prevented had not the individuals
been exposed to Giardia) was 27.5 % (95 % CI: 8.8 to
42.4), which was considerably lower than the AFE for
any of the other functional disorders.
The prevalence of OAB among individuals with no co-
morbid IBS, CF or FD was quite similar in exposed and
controls, with 12.4 % (38/307) in the exposed group and
10.9 % (67/617) among the controls (p = 0.51) (Table 3).
The risk of OAB was significantly increased with having
any comorbid functional disorder in both groups, and
the increase of risk was almost similar in the two groups
(OR: 2.20; 95 % CI: 1.46 to 3.32 in the exposed and OR:
2.40; 95 % CI: 1.56 to 3.70 in the control group; test for
interaction: p = 0.770). However, the risk of concomitant
OAB differed widely between individual functional disor-
ders. OAB was not significantly associated with post-
infectious IBS in the Giardia exposed group, but strongly
associated with sporadic IBS in the control group, and the
risk difference was borderline significant (p = 0.051). Con-
trary to this, OAB was strongly associated with CF inde-
pendent of post-infectious status, and finally, OAB was
only weakly associated with FD independent of post-
infectious status (Table 3).
To further investigate how the functional disorders
interact with each other, we conducted the analysis
shown in Table 4. The table displays odds ratios for as-
sociations between OAB and each of the other three
functional disorders, with successive exclusion of the
remaining two functional disorders. For IBS, the risk of
OAB in the control group remained generally unaltered
regardless of other comorbid disorders (ranging from
OR 2.66 for all IBS to an OR of 2.46 for IBS only),
whereas the already lower risk for the Giardia exposed
Table 1 Population characteristics and demographics of 724
Giardia exposed and 847 controls six years after an outbreak of
Giardia in Bergen, Norway 2004
All Giardia exposed Controls
N n % n % p-valuea)
Gender 0.666
Female 1058 492 68.0 566 66.8
Male 513 232 32.0 281 33.2
Age 0.461
18-40 1015 473 65.3 542 64.0
41-60 424 197 27.2 227 26.8
> 60 132 54 7.5 78 9.2
Marital status 0.003
Single 340 185 25.6 155 18.4
Married 1130 499 69.1 631 74.8
Divorced 75 28 3.9 47 5.6
Widowed 21 10 1.4 11 1.3
Level of education <0.001
Primary school 64 17 2.4 47 5.6
Secondary school 356 134 18.7 222 26.6
University/college 1134 567 79.0 567 67.8
Main occupation 0.097
Working 1249 561 78.0 688 81.5
Unemployed/retired 182 88 12.2 94 11.1
Student 100 49 6.8 51 6.0
Other 32 21 2.9 11 1.3
Groups were matched by gender and age
a) p-value for the difference between the Giardia exposed and the control
group was calculated with Pearson’s exact χ2 test
Persson et al. BMC Gastroenterology  (2015) 15:66 Page 3 of 7
was reduced substantially when comorbidity of FD and
CF were taken into account (ranging from OR 1.90 for
all IBS to an OR of 0.95 for IBS only). For CF, the risk of
OAB remained of the same magnitude in both the ex-
posed and the control group when comorbidity of FD
and IBS was excluded (Table 4). For FD, the risk of OAB
was considerably reduced and remained insignificant in
both the Giardia exposed and control group when co-
morbidity of IBS and CF was excluded.
Discussion
We found a significantly higher prevalence of OAB in
the Giardia exposed group as compared to the control
group, yet the difference was much smaller than for IBS,
CF and even FD. Furthermore, we found a strong associ-
ation between OAB and concomitant functional disor-
ders in the Giardia exposed as well as the control group,
but associations differed between the individual disorders.
OAB did not at all seem to be related to post-infectious
IBS, but strongly related to sporadic IBS. Conversely, OAB
was strongly associated with CF disregarded the post-
infectious status. Finally, our data showed no certain asso-
ciation between OAB and FD, as the apparent tendency to
symptom overlap in the Giardia exposed group disap-
peared when comorbidity with CF and IBS was taken
into account.
It can be assumed that the majority of the individuals
affected had not previously been exposed to Giardia as
the parasite is non-endemic and no outbreaks have oc-
curred in the area previously. Although the response rate
was lower in the control group than in the Giardia ex-
posed, the overall response rate was satisfactory com-
pared to other studies of this kind. There is nonetheless
the risk that selection bias may have skewed prevalence
Table 2 Prevalence and attributable fraction in the Giardia exposed for four functional disorders six years after initial outbreak of
Giardia in Bergen, Norway 2004
Disorder All Giardia exposed Controls
(N = 724) (N = 847)
N n % n % p-valueb) AFE 95 % CI
No functional disordera) 819 269 38.2 550 68.3 <0.001 n.a. n.a.
Overactive bladder syndrome 247 134 18.7 113 13.6 0.007 27.5 (8.8, 42.4)
Irritable bowel syndrome 387 287 40.1 100 11.9 <0.001 70.3 (63.6, 75.8)
Chronic fatigue 320 224 31.6 96 11.4 <0.001 64.0 (57.1, 71.0)
Functional dyspepsia 200 147 21.0 53 6.6 <0.001 68.6 (57.7, 76.7)
Abbreviations: n.a. not applicable; AFE attributable fraction in the exposed, i.e. the proportion of diseased (in percent) that could have been prevented in the
Giardia exposed had the individuals not been exposed to Giardia; CI confidence interval
a) Respondents classified with neither IBS, CF, FD nor OAB; b) p-value for the difference between the Giardia exposed and the control group was calculated with
Pearson’s exact χ2 test
Table 3 Associations between overactive bladder syndrome (OAB) and three different functional disorders among participants who
could be classified with or without OAB (716 Giardia exposed and 833 controls) six years after an outbreak of Giardia in Bergen,
Norway 2004
Disorder Giardia exposed N Controls
N n % OR 95 % CI n % OR 95 % CI p-valueb)
Comorbidity
No comorbidity 307 38 12.4 1.00 reference 617 67 10.9 1.00 reference
Any comorbiditya) 388 92 23.7 2.20 (1.46, 3.32) 181 41 22.7 2.40 (1.56, 3.70) 0.770
Irritable bowel syndrome
No IBS 424 73 17.2 1.00 reference 728 86 11.8 1.00 reference
IBS 284 60 21.1 1.29 (0.88, 1.88) 98 24 24.5 2.42 (1.45, 4.04) 0.051
Chronic Fatigue
No CF 481 65 13.5 1.00 reference 733 86 11.7 1.00 reference
CF 221 66 29.9 2.73 (1.85, 4.02) 96 26 27.1 2.79 (1.69, 4.62) 0.938
Functional dyspepsia
No FD 549 88 16.0 1.00 reference 739 96 13.0 1.00 reference
FD 145 39 26.9 1.93 (1.25, 2.97) 53 10 18.9 1.56 (0.76, 3.20) 0.619
Abbreviations: OAB overactive bladder syndrome; OR odds ratio; CI confidence interval; IBS irritable bowel syndrome; CF chronic fatigue, FD functional dyspepsia
a) Respondents classified with either IBS, CF or FD; b) p-value for effect modification by Breslow-Day test for homogeneity
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estimates in either direction. It is also possible that partici-
pants with functional disorders may have been misclassi-
fied in both groups. Although designated as post-infectious
IBS, the group exposed to Giardia may undoubtedly have
included sporadic IBS as well. We estimated that the frac-
tion of IBS attributable to giardiasis (AFE) in the exposed
group was 70.3 %. Likewise, there is the chance that partic-
ipants classified with IBS in the control group had a pre-
cipitating gastrointestinal infection.
One weakness of the study is that the participants
were diagnosed by the use of questionnaire answers, and
have thereby not been confirmed by a medical examin-
ation. Still, in clinical practice these diagnoses greatly
rely on self-identification of symptoms. The participants
were initially included in the study on the basis of posi-
tive stool samples, which may introduce a source of bias
as healthcare-seeking behaviour will influence the com-
position of the study population, as well as high utilization
of health-care services possibly may result in multiple
diagnoses. However, laboratory confirmation to define
cases of giardiasis is the most reliable option.
Critics of the current OAB definition claim that it may
not indicate a single disease, but rather a collection of
symptoms indirectly or accidently linked to one another
[23]. The imprecision of the OAB definition will result
in a varying interpretation of the case definition that
consequently makes cross-comparability among studies
problematic. Nevertheless, the condition is extensively
studied and relevant to our study objective. The prevalence
of OAB in the control group (13.6 %) was comparable to
earlier large-scale prevalence estimates (11.8 %–16.5 %)
[24–26]. The prevalence was higher in the Giardia exposed
group, but further analyses revealed that there was no asso-
ciation with Giardia exposure for participants without
other functional disorders. This finding suggests that OAB
is not a specific post-infectious complication, but part of a
cluster of functional disorders that may be triggered by
infectious diseases.
Whorwell et al. were first to document that patients
with IBS frequently experience symptoms of an ‘irritable
bladder’ [10]. This relationship has since been reported
several times [11, 12]. It can be argued that IBS is not
associated to OAB specifically, but to symptoms of the
lower urinary tract in general [9]. However, the relation
to post-infectious and sporadic IBS has not been separ-
ately evaluated in earlier studies. The present study
provides the first evidence to suggest that unlike spor-
adic IBS, post-infectious IBS is not associated with an
increased risk of OAB. It is not clear if this association is
pathogen specific, or if it may be inferred to other forms
of enteric infection.
Our research group has previously reported a strong
association between acute giardiasis with increased preva-
lence of IBS and CF 3 years after initial infection [6]. A
Table 4 Associations between overactive bladder syndrome (OAB) and three different functional disorders in participants who could
be classified with or without OAB (716 Giardia exposed and 833 controls) by stratification of comorbid conditions six years after an
outbreak of Giardia in Bergen, Norway 2004
Comorbidities Giardia exposed Controls
N n % OR 95 % CI N n % OR 95 % CI
No comorbiditya) 307 38 12.4 1.00 reference 617 67 10.9 1.00 reference
Irritable bowel syndrome
All IBS 284 60 21.1 1.90 (1.22, 2.95) 98 24 24.5 2.66 (1.57, 4.50)
Without FD 166 27 16.3 1.38 (0.81, 2.35) 67 17 25.4 2.79 (1.52, 5.11)
Without CF 145 23 15.9 1.34 (0.76, 2.34) 68 14 20.6 2.13 (1.12, 4.04)
IBS alone 93 11 11.8 0.95 (0.46, 1.94) 52 12 23.1 2.46 (1.23, 4.93)
Chronic Fatigue
All CF 221 66 29.9 3.01 (1.93, 4.70) 96 26 27.1 3.05 (1.82, 5.11)
Without FD 138 37 26.8 2.59 (1.56, 4.31) 67 17 25.4 2.79 (1.52, 5.11)
Without IBS 84 30 35.7 3.93 (2.24, 6.89) 64 15 23.4 2.51 (1.33, 4.73)
CF alone 65 22 33.8 3.62 (1.96, 6.71) 52 12 23.1 2.46 (1.23, 4.93)
Functional dyspepsia
All FD 145 39 26.9 2.61 (1.58, 4.29) 53 10 18.9 1.91 (0.92, 3.98)
Without IBS 29 7 24.1 2.25 (0.90, 5.63) 23 3 13.0 1.23 (0.36, 4.25)
Without CF 64 12 18.8 1.63 (0.80, 3.34) 30 2 6.7 0.59 (0.14, 2.52)
FD alone 14 1 7.1 0.55 (0.69, 4.28) 16 0 0.0 n.a. n.a.
Abbreviations: OAB overactive bladder syndrome; OR odds ratio; CI confidence interval; IBS irritable bowel syndrome; CF chronic fatigue; FD functional dyspepsia;
n.a. not applicable
a) Respondents classified with neither IBS, CF nor FD
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recent publication shows that a high prevalence of IBS
and CF persists 6 years on, but that post-infectious IBS
may allow for a higher rate of recovery than sporadic
IBS [7]. Considering that post-infectious IBS not only
demonstrates a favourable prognosis, but also a distinct
comorbidity contrasting that of sporadic IBS, strengthens
the claim that post-infectious IBS is a unique subgroup
of IBS.
In one study by Matsuzaki et al. the association
between OAB and FD/IBS was investigated using an
Internet based survey comprising 5494 participants. The
authors conclude that IBS and FD are independently
associated with OAB (OR: 2.63; 95 % CI: 2.12 to 3.27
and OR: 2.85; 95 % CI: 2.21 to 3.67, respectively) [12].
Contrary to these results, our data suggest that FD
carries no inherent risk for association with OAB in the
absence of the other functional disorders investigated.
We recognize that fewer subjects were available for this
analysis.
This study also demonstrates a significant increase in
prevalence of FD in the group exposed to Giardia 6 years
after acute illness as compared to the control group,
with an attributable fraction comparable to that of IBS
and CF. Giardia lamblia infection has earlier been asso-
ciated to FD by the research group, although a control
group was then not included for comparison [27].
Several disorders are recognized to cause enduring
fatigue [13, 14]. Because somatic or psychiatric diseases
have not been formally excluded, the classification of CF
could comprise numerous disorders in addition to CFS.
The association between CFS and both IBS and FD has
previously been shown [5, 28]. This study provides evi-
dence that there exists a high rate of overlap between
OAB and CF, essentially independent of aetiology and
comorbidity.
The mechanisms of disease overlap in most functional
disorders remain unsolved. Proposed theories for comor-
bidity of bladder and bowel disease include mechanisms
of cross-sensitization in which the neural pathways act as
a conduit for smooth muscle dysfunction [29]. However,
explanatory models based on functional convergence
and structural proximity are largely based on animal
models and fail to incorporate conditions considered
“unrelated”. Whitehead et al. challenge prevailing views
by arguing that IBS shows a general amplification in
disease incidence, and that comorbidity may be caused
by a tendency of the patient to over-interpret any som-
atic sensations rather than having common patho-
physiological mechanisms [30]. Although the study has
its own limitations [31], patient vulnerability may be of
special importance and disease mechanisms of func-
tional disorders may possibly only be explained by a
multidimensional model that includes both pathogen
and host factors [9].
Further studies are necessary to evaluate the true
extent of post-infectious complications classified as func-
tional disorders, as well as differences in comorbid risk
between sporadic and post-infectious conditions.
Conclusions
The data presented in this article demonstrates that
6 years after Giardia infection in a non-endemic area
there is a higher prevalence of OAB as compared to a
control group, but this association disappeared when co-
morbid disorders were controlled for. We also show that
only sporadic IBS is significantly associated to increased
risk of OAB. Furthermore, our research demonstrates
that CF conveys an increased and inherent risk for co-
morbidity with OAB, irrespective of other comorbidity
and aetiology (i.e. post-infectious or sporadic). Finally,
we reason that an apparent association between FD and
OAB may be accentuated by, or entirely ascribed to, co-
morbidity of related conditions. Elucidating these associ-
ations may help to advance our understanding and
ultimately have practical consequences in both clinical
diagnosis and patient treatment.
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